Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Pharming Group N.V. - Filing #5829944

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
8,492,000 USD
12,012,000 USD
Revenue
297,200,000 USD
245,316,000 USD
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
1,795,000 USD
17,302,000 USD
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
31,618,000 USD
129,388,000 USD
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
34,412,000 USD
1,039,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.